These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10734823)

  • 21. [A pilot study of methylphenidate and parent training in the treatment of children with attention-deficit hiperactivity disorder].
    Montiel Nava C; Peña JA; Espina Mariñes G; Ferrer-Hernandez ME; López-Rubio A; Puertas-Sánchez S; Cardozo-Durán JJ
    Rev Neurol; 2002 Aug 1-15; 35(3):201-5. PubMed ID: 12235578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zeroing in on attention deficit disorder.
    Health News; 1999 Feb; 5(2):7. PubMed ID: 9972114
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of conscious control on handwriting in children with attention deficit hyperactivity disorder.
    Tucha O; Lange KW
    J Atten Disord; 2005 Aug; 9(1):323-32. PubMed ID: 16371678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
    Johnson KA; Barry E; Bellgrove MA; Cox M; Kelly SP; Dáibhis A; Daly M; Keavey M; Watchorn A; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Gill M
    Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
    Corkum P; Panton R; Ironside S; Macpherson M; Williams T
    J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.
    Vaughan BS; Wetzel MW; Kratochvil CJ
    Int Rev Psychiatry; 2008 Apr; 20(2):143-9. PubMed ID: 18386204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADHD remains clinical challenge: data indicate need for closer follow-up of treated children.
    Golden W; Kinggard TE
    J Ark Med Soc; 2007 Jun; 103(12):297-8. PubMed ID: 17585709
    [No Abstract]   [Full Text] [Related]  

  • 33. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 34. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical review: evidence-based diagnosis and treatment of ADHD in children.
    Nair J; Ehimare U; Beitman BD; Nair SS; Lavin A
    Mo Med; 2006; 103(6):617-21. PubMed ID: 17256270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adults with ADHD: ignored and under-treated.
    Drug and Therapeutics Bulletin
    Drug Ther Bull; 2011 Jul; 49(7):73. PubMed ID: 21752832
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
    Rastmanesh R
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Follow-up of the MTA-study in children with ADHD: what do the data tell us, and what not?].
    Buitelaar JK
    Tijdschr Psychiatr; 2010; 52(4):255-7. PubMed ID: 20503166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.